Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Listen now
Description
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ
More Episodes
Interview with Paulina Salminen, MD, PhD, and Jussi Haijanen, MD, PhD, authors of Three-Year Outcomes of Oral Antibiotics vs Intravenous and Oral Antibiotics for Uncomplicated Acute Appendicitis: A Secondary Analysis of the APPAC II Randomized Clinical Trial. Hosted by Amalia L. Cochran, MD. ...
Published 04/17/24
Published 04/17/24
Interview with Laura Koskenvuo, MD, PhD, and Ville Sallinen, MD, PhD, authors Morbidity After Mechanical Bowel Preparation and Oral Antibiotics Prior to Rectal Resection: The MOBILE2 Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Morbidity After Mechanical Bowel...
Published 03/20/24